KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elanco Animal Health (ELAN) EBIT (2017 - 2026)

Elanco Animal Health's EBIT history spans 9 years, with the latest figure at $158.0 million for Q4 2025.

  • On a quarterly basis, EBIT rose 128.62% to $158.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $795.0 million, a 152.48% increase, with the full-year FY2025 number at $795.0 million, up 152.48% from a year prior.
  • EBIT hit $158.0 million in Q4 2025 for Elanco Animal Health, down from $167.0 million in the prior quarter.
  • Over the last five years, EBIT for ELAN hit a ceiling of $249.0 million in Q1 2025 and a floor of -$1.6 billion in Q3 2023.
  • Historically, EBIT has averaged -$426.6 million across 5 years, with a median of -$514.5 million in 2022.
  • Biggest five-year swings in EBIT: crashed 206.98% in 2023 and later skyrocketed 149.5% in 2025.
  • Tracing ELAN's EBIT over 5 years: stood at -$635.0 million in 2021, then grew by 15.43% to -$537.0 million in 2022, then dropped by 19.74% to -$643.0 million in 2023, then rose by 14.15% to -$552.0 million in 2024, then surged by 128.62% to $158.0 million in 2025.
  • Business Quant data shows EBIT for ELAN at $158.0 million in Q4 2025, $167.0 million in Q3 2025, and $221.0 million in Q2 2025.